Most lately, it has been identified that conolidine and the above derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in related spots as classical opioid receptors, it binds to a big range of endogenous opioids. Not like most opioid receptors, this receptor functions like a scavenger and isn't going to activate a second